A very useful synopsis of treatment strategies for a vexing lethal condition.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
February 27, 2019
February 19, 2019
In this video, the authors demonstrate the Perclose® suture mediated closure technique for closure of the femoral artery after transcatheter aortic valve replacement.
February 13, 2019
This Cardiac Surgery Essentials series from Guest Editor Dr Tsuyoshi Kaneko illustrates basic skills that cardiac surgeons need to possess in their everyday practice, with videos that focus on important aspects of procedures for which demonstrations can be difficult to find.
January 11, 2019
Patient Care and General Interest Ireland’s Cabinet is expected to consider opt-out organ donation legislation this spring.
January 4, 2019
Edwards Lifesciences announced that the SAPIEN 3 Ultra system has received US Food and Drug Administration approval for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are determined to be at intermediate or greater risk of open-heart surgery.
January 2, 2019
Loger and colleagues implanted transcatheter prostheses in the mitral valve position in 33 pigs. Valve performance and heart function were analyzed for both supra-annular and subvalvular fixation.
December 18, 2018
The authors, using the STS/ACC TVT Registry, analyzed the the occurrence of patient-prosthesis mismatch (PPM) in 62,215 patients enrolled between 2014 and 2017. They found that severe and moderate PPM occurred in 12% and 25% of patients, respectively.
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial
December 18, 2018
This study analyzed the cost-effectiveness of TAVR versus SAVR in 3110 intermediate-risk aortic stenosis patients from the PARTNER-2 trial. Using a Markov model, the authors found that TAVR is economically dominant from the perspective of lifetime cost-effectiveness in the US healthcare system.
Clinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Aortic Valves by Four-Dimensional Computed Tomography
December 10, 2018
Basra and colleagues report that among patients with bioprosthetic aortic valves who had clinical or echocardiographic indications suggestive of leaflet thrombosis, one-third of patients had this diagnosis confirmed by four-dimensional computed tomography (4DCT).
December 6, 2018
Leanne Harling talks with John McKenna about the role of industry in cardiothoracic surgical advances.